Albert David（524075）株式概要アルバート・デイビッド・リミテッドは、インドで医薬製剤、輸液、ハーブ剤、原薬などを製造・販売している。 詳細524075 ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長0/6過去の実績0/6財務の健全性3/6配当金1/6リスク分析過去5年間で収益は年間11.1%減少しました。 0.71%の配当は、利益やフリーキャッシュフローによって十分にカバーされていない 意味のある時価総額がありません ( ₹4B )すべてのリスクチェックを見る524075 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value₹Current Price₹702.9043.9% 割安 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-15m4b2016201920222025202620282031Revenue ₹4.0bEarnings ₹588.1mAdvancedSet Fair ValueView all narrativesAlbert David Limited 競合他社Amanta HealthcareSymbol: NSEI:AMANTAMarket cap: ₹4.5bInfinium PharmachemSymbol: NSEI:INFINIUMMarket cap: ₹3.3bHaleos LabsSymbol: NSEI:HALEOSLABSMarket cap: ₹5.0bZIM LaboratoriesSymbol: BSE:541400Market cap: ₹5.4b価格と性能株価の高値、安値、推移の概要Albert David過去の株価現在の株価₹702.9052週高値₹959.3552週安値₹581.30ベータ0.271ヶ月の変化-5.77%3ヶ月変化-3.84%1年変化-12.88%3年間の変化23.91%5年間の変化51.26%IPOからの変化4,885.11%最新ニュースDeclared Dividend • May 14Dividend of ₹5.00 announcedDividend of ₹5.00 is the same as last year. Ex-date: 30th July 2026 Payment date: 5th September 2026 Dividend yield will be 0.7%, which is lower than the industry average of 0.8%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months and having no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments.お知らせ • May 13Albert David Limited, Annual General Meeting, Aug 06, 2026Albert David Limited, Annual General Meeting, Aug 06, 2026.お知らせ • May 04Albert David Limited to Report Q4, 2026 Results on May 12, 2026Albert David Limited announced that they will report Q4, 2026 results on May 12, 2026Reported Earnings • Feb 14Third quarter 2026 earnings released: EPS: ₹26.81 (vs ₹16.45 loss in 3Q 2025)Third quarter 2026 results: EPS: ₹26.81 (up from ₹16.45 loss in 3Q 2025). Revenue: ₹1.02b (up 23% from 3Q 2025). Net income: ₹153.0m (up ₹246.9m from 3Q 2025). Profit margin: 15% (up from net loss in 3Q 2025). Over the last 3 years on average, earnings per share has fallen by 41% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings.お知らせ • Feb 02Albert David Limited to Report Q3, 2026 Results on Feb 11, 2026Albert David Limited announced that they will report Q3, 2026 results on Feb 11, 2026Reported Earnings • Nov 14Second quarter 2026 earnings released: ₹5.79 loss per share (vs ₹31.67 profit in 2Q 2025)Second quarter 2026 results: ₹5.79 loss per share (down from ₹31.67 profit in 2Q 2025). Revenue: ₹851.0m (down 14% from 2Q 2025). Net loss: ₹33.0m (down 118% from profit in 2Q 2025). Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings.最新情報をもっと見るRecent updatesDeclared Dividend • May 14Dividend of ₹5.00 announcedDividend of ₹5.00 is the same as last year. Ex-date: 30th July 2026 Payment date: 5th September 2026 Dividend yield will be 0.7%, which is lower than the industry average of 0.8%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months and having no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments.お知らせ • May 13Albert David Limited, Annual General Meeting, Aug 06, 2026Albert David Limited, Annual General Meeting, Aug 06, 2026.お知らせ • May 04Albert David Limited to Report Q4, 2026 Results on May 12, 2026Albert David Limited announced that they will report Q4, 2026 results on May 12, 2026Reported Earnings • Feb 14Third quarter 2026 earnings released: EPS: ₹26.81 (vs ₹16.45 loss in 3Q 2025)Third quarter 2026 results: EPS: ₹26.81 (up from ₹16.45 loss in 3Q 2025). Revenue: ₹1.02b (up 23% from 3Q 2025). Net income: ₹153.0m (up ₹246.9m from 3Q 2025). Profit margin: 15% (up from net loss in 3Q 2025). Over the last 3 years on average, earnings per share has fallen by 41% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings.お知らせ • Feb 02Albert David Limited to Report Q3, 2026 Results on Feb 11, 2026Albert David Limited announced that they will report Q3, 2026 results on Feb 11, 2026Reported Earnings • Nov 14Second quarter 2026 earnings released: ₹5.79 loss per share (vs ₹31.67 profit in 2Q 2025)Second quarter 2026 results: ₹5.79 loss per share (down from ₹31.67 profit in 2Q 2025). Revenue: ₹851.0m (down 14% from 2Q 2025). Net loss: ₹33.0m (down 118% from profit in 2Q 2025). Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings.お知らせ • Nov 03Albert David Limited to Report Q2, 2026 Results on Nov 12, 2025Albert David Limited announced that they will report Q2, 2026 results on Nov 12, 2025お知らせ • Jul 25Albert David Limited to Report Q1, 2026 Results on Aug 02, 2025Albert David Limited announced that they will report Q1, 2026 results at 12:15 PM, Indian Standard Time on Aug 02, 2025Upcoming Dividend • Jul 18Upcoming dividend of ₹5.00 per shareEligible shareholders must have bought the stock before 25 July 2025. Payment date: 07 August 2025. Payout ratio is a comfortable 17% but the company is not cash flow positive. Trailing yield: 0.5%. Lower than top quartile of Indian dividend payers (1.2%). Lower than average of industry peers (0.8%).Reported Earnings • Jul 10Full year 2025 earnings released: EPS: ₹30.14 (vs ₹132 in FY 2024)Full year 2025 results: EPS: ₹30.14 (down from ₹132 in FY 2024). Revenue: ₹3.46b (down 4.6% from FY 2024). Net income: ₹172.0m (down 77% from FY 2024). Profit margin: 5.0% (down from 21% in FY 2024). Over the last 3 years on average, earnings per share has increased by 13% per year whereas the company’s share price has increased by 16% per year.Declared Dividend • May 15Dividend reduced to ₹5.00Dividend of ₹5.00 is 57% lower than last year. Ex-date: 25th July 2025 Payment date: 1st September 2025 Dividend yield will be 0.6%, which is lower than the industry average of 0.8%. Sustainability & Growth Dividend is covered by earnings (9% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 8.7% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to decline by 90% to shift the payout ratio to a potentially unsustainable range, which is more than the 2.1% EPS decline seen over the last 5 years.お知らせ • May 14+ 1 more updateAlbert David Limited, Annual General Meeting, Aug 02, 2025Albert David Limited, Annual General Meeting, Aug 02, 2025.Reported Earnings • May 14Full year 2025 earnings released: EPS: ₹30.14 (vs ₹132 in FY 2024)Full year 2025 results: EPS: ₹30.14 (down from ₹132 in FY 2024). Revenue: ₹3.75b (up 3.6% from FY 2024). Net income: ₹172.0m (down 77% from FY 2024). Profit margin: 4.6% (down from 21% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 13% per year whereas the company’s share price has increased by 15% per year.New Risk • May 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (8.8% average weekly change). Profit margins are more than 30% lower than last year (11% net profit margin). Market cap is less than US$100m (₹5.14b market cap, or US$60.5m).お知らせ • Mar 10Albert David Limited Announces Resignation of Shirish Gundopant Belapure as Independent DirectorAlbert David Limited announced that Mr. Shirish Gundopant Belapure has tendered his resignation as an Independent Director of the company, with effect from March 10, 2025.Valuation Update With 7 Day Price Move • Feb 19Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to ₹879, the stock trades at a trailing P/E ratio of 12.4x. Average trailing P/E is 28x in the Pharmaceuticals industry in India. Total returns to shareholders of 69% over the past three years.New Risk • Feb 13New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 12% Last year net profit margin: 19% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (12% net profit margin). Market cap is less than US$100m (₹6.29b market cap, or US$72.4m).Reported Earnings • Feb 13Third quarter 2025 earnings released: ₹16.45 loss per share (vs ₹32.80 profit in 3Q 2024)Third quarter 2025 results: ₹16.45 loss per share (down from ₹32.80 profit in 3Q 2024). Revenue: ₹740.8m (down 16% from 3Q 2024). Net loss: ₹93.9m (down 150% from profit in 3Q 2024). Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth.お知らせ • Feb 01Albert David Limited to Report Q3, 2025 Results on Feb 12, 2025Albert David Limited announced that they will report Q3, 2025 results at 12:15 PM, Indian Standard Time on Feb 12, 2025Reported Earnings • Nov 17Second quarter 2025 earnings released: EPS: ₹31.67 (vs ₹35.57 in 2Q 2024)Second quarter 2025 results: EPS: ₹31.67 (down from ₹35.57 in 2Q 2024). Revenue: ₹1.19b (up 28% from 2Q 2024). Net income: ₹180.7m (down 11% from 2Q 2024). Profit margin: 15% (down from 22% in 2Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 31% per year and the company’s share price has also increased by 31% per year.お知らせ • Nov 09Albert David Limited to Report Q2, 2025 Results on Nov 14, 2024Albert David Limited announced that they will report Q2, 2025 results on Nov 14, 2024Buy Or Sell Opportunity • Aug 29Now 24% overvalued after recent price riseOver the last 90 days, the stock has risen 46% to ₹1,630. The fair value is estimated to be ₹1,314, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 8.3% over the last 3 years. Earnings per share has grown by 31%.Valuation Update With 7 Day Price Move • Aug 28Investor sentiment improves as stock rises 24%After last week's 24% share price gain to ₹1,555, the stock trades at a trailing P/E ratio of 12.5x. Average trailing P/E is 39x in the Pharmaceuticals industry in India. Total returns to shareholders of 185% over the past three years.お知らせ • Aug 09Albert David Limited Approves Dividend for the Financial Year Ended on March 31, 2024Albert David Limited at the Annual General Meeting held on August 9, 2024 approved declaration of Dividend of INR 11.50 per equity share of INR 10 each for the financial year ended on March 31, 2024.Buy Or Sell Opportunity • Jul 29Now 20% overvalued after recent price riseOver the last 90 days, the stock has risen 11% to ₹1,326. The fair value is estimated to be ₹1,104, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years. Earnings per share has grown by 33%.Upcoming Dividend • Jul 26Upcoming dividend of ₹11.50 per shareEligible shareholders must have bought the stock before 02 August 2024. Payment date: 08 September 2024. Payout ratio is a comfortable 8.7% and this is well supported by cash flows. Trailing yield: 0.9%. Lower than top quartile of Indian dividend payers (1.1%). Higher than average of industry peers (0.7%).Reported Earnings • Jul 15Full year 2024 earnings released: EPS: ₹132 (vs ₹63.39 in FY 2023)Full year 2024 results: EPS: ₹132 (up from ₹63.39 in FY 2023). Revenue: ₹3.62b (up 6.1% from FY 2023). Net income: ₹754.2m (up 109% from FY 2023). Profit margin: 21% (up from 11% in FY 2023). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 33% per year whereas the company’s share price has increased by 34% per year.Buy Or Sell Opportunity • Jul 01Now 23% overvalued after recent price riseOver the last 90 days, the stock has risen 22% to ₹1,362. The fair value is estimated to be ₹1,104, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years. Earnings per share has grown by 33%.Buy Or Sell Opportunity • Jun 21Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 21% to ₹1,334. The fair value is estimated to be ₹1,104, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years. Earnings per share has grown by 33%.Valuation Update With 7 Day Price Move • Jun 12Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₹1,270, the stock trades at a trailing P/E ratio of 9.6x. Average trailing P/E is 33x in the Pharmaceuticals industry in India. Total returns to shareholders of 155% over the past three years.Declared Dividend • May 15Dividend of ₹11.50 announcedShareholders will receive a dividend of ₹11.50. Ex-date: 2nd August 2024 Payment date: 8th September 2024 Dividend yield will be 1.0%, which is higher than the industry average of 0.8%. Sustainability & Growth Dividend is well covered by both earnings (14% earnings payout ratio) and cash flows (15% cash payout ratio). The dividend has increased by an average of 7.2% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 34% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.お知らせ • May 15Albert David Limited, Annual General Meeting, Aug 09, 2024Albert David Limited, Annual General Meeting, Aug 09, 2024.Reported Earnings • May 14Full year 2024 earnings released: EPS: ₹132 (vs ₹63.39 in FY 2023)Full year 2024 results: EPS: ₹132 (up from ₹63.39 in FY 2023). Revenue: ₹4.20b (up 23% from FY 2023). Net income: ₹754.2m (up 109% from FY 2023). Profit margin: 18% (up from 11% in FY 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has increased by 39% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • May 07Albert David Limited to Report Q4, 2024 Results on May 13, 2024Albert David Limited announced that they will report Q4, 2024 results on May 13, 2024お知らせ • May 06Albert David Limited Announces Resignation of Abhishek Seth as Company Secretary & Compliance Officer, Effective May 31, 2024Albert David Limited informed that Mr. Abhishek Seth (ACS - 39671), Company Secretary & Compliance Officer, has resigned from the services of the Company effective May 31, 2024, in view of career opportunity outside the organization. In view of the resignation, Mr. Seth will also cease to be a Key Managerial Person under the provisions of Section 203 and other applicable provisions, if any, of the Companies Act, 2013 and Regulation 30(5) of the SEBI Listing Regulations for determining materiality of events /information for disclosure to the Stock Exchanges.New Risk • Apr 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.5% average weekly change). Market cap is less than US$100m (₹6.90b market cap, or US$82.8m).お知らせ • Mar 14Albert David Limited Announces Management ChangesAlbert David Limited at its board meeting held on 14 March 2024 announced that Based on the recommendation of the Nomination and Remuneration Committee of the Company, appointed Mr. Abhishek Seth (ACS-39671) as the Company Secretary & Compliance Officer, Nodal Officer (IEPF) and Chief Investor Relations Officer of the Company effective 14th March 2024 and Noted that Mr. Rajiv Singhi (DIN:00071285) and Mr. Hemal Kampani (DIN:00057715), Independent Directors of the Company, will be completing their second & final term as Independent Directors effective end of day 31st March 2024, and, thus, placed on record their appreciation for the retiring Directors. Reason for change of Mr. Abhishek Seth: In view of resignation of earlier Company Secretary & Compliance Officer-cum-Legal Head of the Company, and, based on recommendation of the Nomination and Remuneration Committee of the Company, the Board has appointed Mr. Abhishek Seth as the Company Secretary & Compliance Officer of the Company, who shall also function as the Nodal Officer (IEPF) and Chief Investor Relations Officer. Mr. Abhishek Seth is an Associate Member of the Institute of Company Secretaries of India (Membership No. 39671) and holds a Master's in Economics from University of Calcutta. He has around 9 years of post-qualification experience in the Corporate Secretarial and Compliance domain. He has been associated with Albert David Limited for nearly 8 years across Corporate Secretarial, Compliance and Finance functions. Prior to association with Albert David Limited, he was associated with Bengal Shelter Housing Development Limited as Company Secretary.Reported Earnings • Feb 06Third quarter 2024 earnings released: EPS: ₹32.80 (vs ₹18.48 in 3Q 2023)Third quarter 2024 results: EPS: ₹32.80 (up from ₹18.48 in 3Q 2023). Revenue: ₹1.05b (up 41% from 3Q 2023). Net income: ₹187.2m (up 78% from 3Q 2023). Profit margin: 18% (up from 14% in 3Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has increased by 47% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Jan 26Albert David Limited to Report Q3, 2024 Results on Feb 05, 2024Albert David Limited announced that they will report Q3, 2024 results on Feb 05, 2024Valuation Update With 7 Day Price Move • Jan 21Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹1,274, the stock trades at a trailing P/E ratio of 12.5x. Average trailing P/E is 35x in the Pharmaceuticals industry in India. Total returns to shareholders of 208% over the past three years.お知らせ • Nov 23Albert David Limited Announces Resignation of A. B. Chakrabartty as Company Secretary and Compliance Officer Cum Legal Head of the CompanyAlbert David Limited announced that Mr. A. B. Chakrabartty (FCS 7184) has conveyed his decision to resign from the post of Company Secretary and Compliance Officer cum Legal Head of the Company, due to career opportunity outside the organization. He will continue to discharge his duties as the Company Secretary and Compliance Officer cum Legal Head of the Company, until the close of business hours on 19 January, 2024 to facilitate smooth transition. The Company has accepted his resignation. Mr. Chakrabartty will also cease to be a Key Managerial Personnel under the provisions of Section 203 and other applicable provisions, if any of the Companies Act, 2023 and Regulation 30(5) of SEBI LODR for determining the materiality of events or transactions for making the required disclosures to the Stock Exchanges effective close of business hours on January 19, 2024.Reported Earnings • Nov 11Second quarter 2024 earnings released: EPS: ₹35.57 (vs ₹35.29 in 2Q 2023)Second quarter 2024 results: EPS: ₹35.57 (up from ₹35.29 in 2Q 2023). Revenue: ₹1.05b (up 14% from 2Q 2023). Net income: ₹203.0m (flat on 2Q 2023). Profit margin: 19% (down from 22% in 2Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has only increased by 27% per year, which means it is significantly lagging earnings growth.お知らせ • Aug 11Albert David Limited Approves Dividend for the Financial Year Ended March 31, 2023Albert David Limited at its AGM held on August 10, 2023 approved dividend of INR 9.00 per equity share of INR 10.00 each for the financial year ended on 31st March, 2023.Reported Earnings • Aug 11First quarter 2024 earnings released: EPS: ₹41.16 (vs ₹3.08 in 1Q 2023)First quarter 2024 results: EPS: ₹41.16 (up from ₹3.08 in 1Q 2023). Revenue: ₹1.10b (up 18% from 1Q 2023). Net income: ₹234.9m (up ₹217.4m from 1Q 2023). Profit margin: 21% (up from 1.9% in 1Q 2023). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has only increased by 18% per year, which means it is significantly lagging earnings growth.お知らせ • Aug 03Albert David Limited to Report Q1, 2024 Results on Aug 10, 2023Albert David Limited announced that they will report Q1, 2024 results on Aug 10, 2023Upcoming Dividend • Jul 27Upcoming dividend of ₹9.00 per share at 1.3% yieldEligible shareholders must have bought the stock before 03 August 2023. Payment date: 09 September 2023. Payout ratio is a comfortable 14% and the cash payout ratio is 98%. Trailing yield: 1.3%. Lower than top quartile of Indian dividend payers (1.5%). Higher than average of industry peers (0.9%).Reported Earnings • May 21Full year 2023 earnings released: EPS: ₹63.39 (vs ₹61.78 in FY 2022)Full year 2023 results: EPS: ₹63.39 (up from ₹61.78 in FY 2022). Revenue: ₹3.57b (up 14% from FY 2022). Net income: ₹361.7m (up 2.6% from FY 2022). Profit margin: 10% (down from 11% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.お知らせ • May 20+ 1 more updateAlbert David Limited, Annual General Meeting, Aug 10, 2023Albert David Limited, Annual General Meeting, Aug 10, 2023. Agenda: To consider dividend for the financial year ended March 31, 2023; and to consider directorate appointments.お知らせ • May 13Albert David Limited to Report Q4, 2023 Results on May 19, 2023Albert David Limited announced that they will report Q4, 2023 results on May 19, 2023Reported Earnings • Feb 15Third quarter 2023 earnings released: EPS: ₹18.48 (vs ₹13.96 in 3Q 2022)Third quarter 2023 results: EPS: ₹18.48 (up from ₹13.96 in 3Q 2022). Revenue: ₹745.7m (up 4.0% from 3Q 2022). Net income: ₹105.5m (up 32% from 3Q 2022). Profit margin: 14% (up from 11% in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth.お知らせ • Feb 07Albert David Limited to Report Q3, 2023 Results on Feb 13, 2023Albert David Limited announced that they will report Q3, 2023 results on Feb 13, 2023お知らせ • Feb 06+ 1 more updateAlbert David Limited Appoints Mr. A B Chakrabartty as the Company Secretary & Compliance Officer Cum Legal Head of the CompanyAlbert David Limited announced that at its board meeting held on February 04, 2023, the board approved the appointment of Mr. A B Chakrabartty as the Company Secretary & Compliance officer cum Legal Head of the company with effect from February 04, 2023.Reported Earnings • Nov 16Second quarter 2023 earnings released: EPS: ₹35.29 (vs ₹22.20 in 2Q 2022)Second quarter 2023 results: EPS: ₹35.29 (up from ₹22.20 in 2Q 2022). Revenue: ₹1.06b (up 23% from 2Q 2022). Net income: ₹201.4m (up 59% from 2Q 2022). Profit margin: 19% (up from 15% in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has only increased by 14% per year, which means it is significantly lagging earnings growth.お知らせ • Nov 05Albert David Limited to Report Q2, 2023 Results on Nov 12, 2022Albert David Limited announced that they will report Q2, 2023 results on Nov 12, 2022お知らせ • Sep 14Albert David Limited Announces Reconstitution of Committees of the Board of DirectorsAlbert David Limited informed that the Board of Directors of the Company in their meeting held on 13 September 2022, has reconstituted the following Committees of the Board of Directors, with immediate effect. Stakeholder Relationship and Grievance Committee: Mr. Hemal Kampani, Chairman, Non-Executive Independent Director, Mr. Arun Kumar Kothari, Member, Executive Director, Mrs. Prabhawati Devi Kothari, Member, Non-Executive Director, Dr. Monjori Mitra, Member, Non-Executive Independent Director. Corporate Social Responsibility Committee: Mr. Arun Kumar Kothari, Chairman, Executive Director, Mrs. Prabhawati Devi Kothari, Member, Non-Executive Director, Mr. Arindam Sarkar, Member, Non-Executive Independent Director and Mr. S. G. Belapure, Member, Non-Executive Independent Director.お知らせ • Sep 09Albert David Limited Announces Resignation of Tarminder Singh Parmar as Managing Director and CEO, Effective December 8, 2022Albert David Limited announced that Mr. Tarminder Singh Parmar, Managing Director and CEO has tendered his resignation from the office of Managing Director and CEO of the company with effect from the close of business hours on December 8, 2022.お知らせ • Aug 17Albert David Limited Announces Management ChangesAlbert David Limited announced that Mr. Chirag A. Vora has tendered his resignation as Company Secretary and Compliance Officer of the Company, due to personal reasons. The Company has accepted his resignation and that Chirag will be relieved from the services of the Company close of business hours on 16 August, 2022. The Company has appointed Dr. Indrajit Dhar as the Compliance Officer of the Company with effect from 17 August, 2022. Brief Profile of Dr. I Dhar Dr. Indrajit Dhar is a qualified Chartered Accountant and Company Secretary being a Associate Member of the Institute of Company Secretaries of having more than 3 decades of post-qualification experience in the Accounts, Taxations, Finance and Secretarial. Presently, Dhar is designated as AVP Accounts and Taxations of the Company.Upcoming Dividend • Jul 25Upcoming dividend of ₹9.00 per shareEligible shareholders must have bought the stock before 01 August 2022. Payment date: 08 September 2022. Payout ratio is a comfortable 15% and this is well supported by cash flows. Trailing yield: 1.5%. Lower than top quartile of Indian dividend payers (1.7%). Higher than average of industry peers (1.0%).Reported Earnings • Jul 17Full year 2022 earnings releasedFull year 2022 results: Revenue: ₹3.14b (up 27% from FY 2021). Net income: ₹352.6m (up 59% from FY 2021). Profit margin: 11% (up from 8.9% in FY 2021).お知らせ • Jul 06Albert David Limited, Annual General Meeting, Aug 09, 2022Albert David Limited, Annual General Meeting, Aug 09, 2022, at 11:00 Indian Standard Time.Recent Insider Transactions • Jun 19Executive Chairman recently bought ₹1.1m worth of stockOn the 13th of June, Arun Kothari bought around 2k shares on-market at roughly ₹526 per share. In the last 3 months, they made an even bigger purchase worth ₹1.4m. Arun has been a buyer over the last 12 months, purchasing a net total of ₹7.3m worth in shares.お知らせ • May 13+ 1 more updateAlbert David Limited Approves the Appointment of Anand Vardhan Kothari as an Additional Director (Non-Executive Non-Independent)Based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors of Albert David Limited has approved the appointment of Mr. Anand Vardhan Kothari (DIN: 02572346) as an Additional Director (Non-Executive Non-Independent) on the Board of the Company with immediate effect, i.e. from May 11, 2022, who shall hold office till the date of the forthcoming Annual General Meeting and shall continue to hold office thereafter, subject to approval of the shareholders at the forthcoming Annual General Meeting of the Company.Reported Earnings • May 13Full year 2022 earnings released: EPS: ₹61.78 (vs ₹38.80 in FY 2021)Full year 2022 results: EPS: ₹61.78 (up from ₹38.80 in FY 2021). Revenue: ₹3.29b (up 33% from FY 2021). Net income: ₹352.6m (up 59% from FY 2021). Profit margin: 11% (up from 8.9% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.Board Change • Apr 27Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 3 experienced directors. 4 highly experienced directors. Additional Non-Executive Independent Director Monjori Mitra was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Recent Insider Transactions • Apr 02Executive Chairman recently bought ₹536k worth of stockOn the 30th of March, Arun Kothari bought around 1k shares on-market at roughly ₹536 per share. In the last 3 months, they made an even bigger purchase worth ₹2.0m. Arun has been a buyer over the last 12 months, purchasing a net total of ₹4.6m worth in shares.Board Change • Apr 01Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 3 experienced directors. 4 highly experienced directors. Additional Non-Executive Independent Director Monjori Mitra was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Recent Insider Transactions • Mar 16Executive Chairman recently bought ₹1.6m worth of stockOn the 9th of March, Arun Kothari bought around 3k shares on-market at roughly ₹521 per share. In the last 3 months, they made an even bigger purchase worth ₹2.0m. Arun has been a buyer over the last 12 months, purchasing a net total of ₹3.7m worth in shares.Board Change • Mar 02Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 3 experienced directors. 4 highly experienced directors. Additional Non-Executive Independent Director Monjori Mitra was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Feb 17Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹13.96 (up from ₹10.72 in 3Q 2021). Revenue: ₹777.3m (up 19% from 3Q 2021). Net income: ₹79.7m (up 30% from 3Q 2021). Profit margin: 10% (in line with 3Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Jan 03Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹676, the stock trades at a trailing P/E ratio of 10.6x. Average trailing P/E is 26x in the Pharmaceuticals industry in India. Total returns to shareholders of 71% over the past three years.Reported Earnings • Nov 16Second quarter 2022 earnings released: EPS ₹22.20 (vs ₹17.16 in 2Q 2021)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2022 results: Revenue: ₹863.4m (up 20% from 2Q 2021). Net income: ₹126.7m (up 29% from 2Q 2021). Profit margin: 15% (in line with 2Q 2021). Over the last 3 years on average, earnings per share has increased by 11% per year whereas the company’s share price has increased by 13% per year.Upcoming Dividend • Aug 30Upcoming dividend of ₹6.00 per shareEligible shareholders must have bought the stock before 06 September 2021. Payment date: 14 October 2021. Trailing yield: 1.0%. Lower than top quartile of Indian dividend payers (1.5%). Higher than average of industry peers (0.8%).Reported Earnings • Aug 18First quarter 2022 earnings released: EPS ₹18.30 (vs ₹7.65 in 1Q 2021)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: ₹861.5m (up 37% from 1Q 2021). Net income: ₹104.5m (up 139% from 1Q 2021). Profit margin: 12% (up from 7.0% in 1Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 3% per year whereas the company’s share price has increased by 2% per year.Valuation Update With 7 Day Price Move • Aug 12Investor sentiment improved over the past weekAfter last week's 19% share price gain to ₹634, the stock trades at a trailing P/E ratio of 16.3x. Average trailing P/E is 26x in the Pharmaceuticals industry in India. Total returns to shareholders of 18% over the past three years.Reported Earnings • Jun 20Full year 2021 earnings released: EPS ₹38.80 (vs ₹33.59 in FY 2020)The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2021 results: Revenue: ₹2.47b (down 23% from FY 2020). Net income: ₹221.4m (up 16% from FY 2020). Profit margin: 8.9% (up from 6.0% in FY 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings.Recent Insider Transactions • Apr 04Insider recently bought ₹189k worth of stockOn the 30th of March, Anand Kothari bought around 500 shares on-market at roughly ₹379 per share. In the last 3 months, there was an even bigger purchase from another insider worth ₹199k. Insiders have collectively bought ₹389k more in shares than they have sold in the last 12 months.Recent Insider Transactions • Mar 31Executive Chairman recently bought ₹199k worth of stockOn the 22nd of March, Arun Kothari bought around 500 shares on-market at roughly ₹398 per share. This was the largest purchase by an insider in the last 3 months. This was Arun's only on-market trade for the last 12 months.Is New 90 Day High Low • Feb 18New 90-day low: ₹399The company is down 4.0% from its price of ₹416 on 20 November 2020. The Indian market is up 21% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Pharmaceuticals industry, which is up 9.0% over the same period.Reported Earnings • Feb 10Third quarter 2021 earnings released: EPS ₹10.72 (vs ₹9.20 in 3Q 2020)The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: ₹701.8m (down 12% from 3Q 2020). Net income: ₹61.2m (up 17% from 3Q 2020). Profit margin: 8.7% (up from 6.6% in 3Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 3% per year whereas the company’s share price has increased by 2% per year.お知らせ • Feb 03Albert David Limited to Report Q3, 2021 Results on Feb 09, 2021Albert David Limited announced that they will report Q3, 2021 results on Feb 09, 2021Is New 90 Day High Low • Nov 24New 90-day high: ₹459The company is up 1.0% from its price of ₹453 on 26 August 2020. The Indian market is up 10.0% over the last 90 days, indicating the company underperformed over that time. However, its price trend is similar to the Pharmaceuticals industry, which is also up 1.0% over the same period.お知らせ • Nov 12+ 1 more updateAlbert David Limited Announces Executive ChangeAlbert David Limited announced Mr. Subhash Chandra Shah shall retire as Key Managerial Personnel with effect from close of business hours of 30 November, 2020. Mr. Ranadeep Bhattacharya will be appointed as Key Managerial Personnel of the Company with effect from 1st December, 2020.Is New 90 Day High Low • Oct 27New 90-day low: ₹393The company is down 3.0% from its price of ₹405 on 29 July 2020. The Indian market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Pharmaceuticals industry, which is up 12% over the same period.お知らせ • Aug 18Albert David Limited to Report Q1, 2021 Results on Aug 24, 2020Albert David Limited announced that they will report Q1, 2021 results on Aug 24, 2020お知らせ • Jun 28Albert David Limited to Report Q4, 2020 Results on Jun 29, 2020Albert David Limited announced that they will report Q4, 2020 results on Jun 29, 2020株主還元524075IN PharmaceuticalsIN 市場7D-2.8%-0.07%0.5%1Y-12.9%10.3%-0.5%株主還元を見る業界別リターン: 524075過去 1 年間で10.3 % の収益を上げたIndian Pharmaceuticals業界を下回りました。リターン対市場: 524075は、過去 1 年間で-0.5 % のリターンを上げたIndian市場を下回りました。価格変動Is 524075's price volatile compared to industry and market?524075 volatility524075 Average Weekly Movement6.7%Pharmaceuticals Industry Average Movement6.7%Market Average Movement7.1%10% most volatile stocks in IN Market10.1%10% least volatile stocks in IN Market4.8%安定した株価: 524075 、 Indian市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: 524075の 週次ボラティリティ ( 7% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイト19381,805Amit Mahlawww.albertdavidindia.comアルバート・デイビッド社は、インドで医薬製剤、輸液、ハーブ剤、原薬などを製造・販売している。非経口剤、経口・経腸剤、外用剤、ビジョンケア製品などの製剤を提供。中南米、東南アジア、その他アフリカ諸国に製品を輸出している。アルバート・デイビッド社は1938年に設立され、本社はインドのコルカタにある。もっと見るAlbert David Limited 基礎のまとめAlbert David の収益と売上を時価総額と比較するとどうか。524075 基礎統計学時価総額₹4.01b収益（TTM）-₹14.95m売上高(TTM)₹3.34b1.2xP/Sレシオ-268.4xPER（株価収益率524075 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計524075 損益計算書（TTM）収益₹3.34b売上原価₹1.14b売上総利益₹2.20bその他の費用₹2.21b収益-₹14.95m直近の収益報告Mar 31, 2026次回決算日該当なし一株当たり利益（EPS）-2.62グロス・マージン65.87%純利益率-0.45%有利子負債／自己資本比率7.3%524075 の長期的なパフォーマンスは？過去の実績と比較を見る配当金0.7%現在の配当利回り-191%配当性向524075 配当は確実ですか？524075 配当履歴とベンチマークを見る524075 、いつまでに購入すれば配当金を受け取れますか？Albert David 配当日配当落ち日Jul 30 2026配当支払日Sep 05 2026配当落ちまでの日数67 days配当支払日までの日数104 days524075 配当は確実ですか？524075 配当履歴とベンチマークを見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/22 12:03終値2026/05/22 00:00収益2026/03/31年間収益2026/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Albert David Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Kameswari V. S. ChavaliFirstCall Research
Declared Dividend • May 14Dividend of ₹5.00 announcedDividend of ₹5.00 is the same as last year. Ex-date: 30th July 2026 Payment date: 5th September 2026 Dividend yield will be 0.7%, which is lower than the industry average of 0.8%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months and having no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments.
お知らせ • May 13Albert David Limited, Annual General Meeting, Aug 06, 2026Albert David Limited, Annual General Meeting, Aug 06, 2026.
お知らせ • May 04Albert David Limited to Report Q4, 2026 Results on May 12, 2026Albert David Limited announced that they will report Q4, 2026 results on May 12, 2026
Reported Earnings • Feb 14Third quarter 2026 earnings released: EPS: ₹26.81 (vs ₹16.45 loss in 3Q 2025)Third quarter 2026 results: EPS: ₹26.81 (up from ₹16.45 loss in 3Q 2025). Revenue: ₹1.02b (up 23% from 3Q 2025). Net income: ₹153.0m (up ₹246.9m from 3Q 2025). Profit margin: 15% (up from net loss in 3Q 2025). Over the last 3 years on average, earnings per share has fallen by 41% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings.
お知らせ • Feb 02Albert David Limited to Report Q3, 2026 Results on Feb 11, 2026Albert David Limited announced that they will report Q3, 2026 results on Feb 11, 2026
Reported Earnings • Nov 14Second quarter 2026 earnings released: ₹5.79 loss per share (vs ₹31.67 profit in 2Q 2025)Second quarter 2026 results: ₹5.79 loss per share (down from ₹31.67 profit in 2Q 2025). Revenue: ₹851.0m (down 14% from 2Q 2025). Net loss: ₹33.0m (down 118% from profit in 2Q 2025). Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings.
Declared Dividend • May 14Dividend of ₹5.00 announcedDividend of ₹5.00 is the same as last year. Ex-date: 30th July 2026 Payment date: 5th September 2026 Dividend yield will be 0.7%, which is lower than the industry average of 0.8%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months and having no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments.
お知らせ • May 13Albert David Limited, Annual General Meeting, Aug 06, 2026Albert David Limited, Annual General Meeting, Aug 06, 2026.
お知らせ • May 04Albert David Limited to Report Q4, 2026 Results on May 12, 2026Albert David Limited announced that they will report Q4, 2026 results on May 12, 2026
Reported Earnings • Feb 14Third quarter 2026 earnings released: EPS: ₹26.81 (vs ₹16.45 loss in 3Q 2025)Third quarter 2026 results: EPS: ₹26.81 (up from ₹16.45 loss in 3Q 2025). Revenue: ₹1.02b (up 23% from 3Q 2025). Net income: ₹153.0m (up ₹246.9m from 3Q 2025). Profit margin: 15% (up from net loss in 3Q 2025). Over the last 3 years on average, earnings per share has fallen by 41% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings.
お知らせ • Feb 02Albert David Limited to Report Q3, 2026 Results on Feb 11, 2026Albert David Limited announced that they will report Q3, 2026 results on Feb 11, 2026
Reported Earnings • Nov 14Second quarter 2026 earnings released: ₹5.79 loss per share (vs ₹31.67 profit in 2Q 2025)Second quarter 2026 results: ₹5.79 loss per share (down from ₹31.67 profit in 2Q 2025). Revenue: ₹851.0m (down 14% from 2Q 2025). Net loss: ₹33.0m (down 118% from profit in 2Q 2025). Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings.
お知らせ • Nov 03Albert David Limited to Report Q2, 2026 Results on Nov 12, 2025Albert David Limited announced that they will report Q2, 2026 results on Nov 12, 2025
お知らせ • Jul 25Albert David Limited to Report Q1, 2026 Results on Aug 02, 2025Albert David Limited announced that they will report Q1, 2026 results at 12:15 PM, Indian Standard Time on Aug 02, 2025
Upcoming Dividend • Jul 18Upcoming dividend of ₹5.00 per shareEligible shareholders must have bought the stock before 25 July 2025. Payment date: 07 August 2025. Payout ratio is a comfortable 17% but the company is not cash flow positive. Trailing yield: 0.5%. Lower than top quartile of Indian dividend payers (1.2%). Lower than average of industry peers (0.8%).
Reported Earnings • Jul 10Full year 2025 earnings released: EPS: ₹30.14 (vs ₹132 in FY 2024)Full year 2025 results: EPS: ₹30.14 (down from ₹132 in FY 2024). Revenue: ₹3.46b (down 4.6% from FY 2024). Net income: ₹172.0m (down 77% from FY 2024). Profit margin: 5.0% (down from 21% in FY 2024). Over the last 3 years on average, earnings per share has increased by 13% per year whereas the company’s share price has increased by 16% per year.
Declared Dividend • May 15Dividend reduced to ₹5.00Dividend of ₹5.00 is 57% lower than last year. Ex-date: 25th July 2025 Payment date: 1st September 2025 Dividend yield will be 0.6%, which is lower than the industry average of 0.8%. Sustainability & Growth Dividend is covered by earnings (9% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 8.7% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to decline by 90% to shift the payout ratio to a potentially unsustainable range, which is more than the 2.1% EPS decline seen over the last 5 years.
お知らせ • May 14+ 1 more updateAlbert David Limited, Annual General Meeting, Aug 02, 2025Albert David Limited, Annual General Meeting, Aug 02, 2025.
Reported Earnings • May 14Full year 2025 earnings released: EPS: ₹30.14 (vs ₹132 in FY 2024)Full year 2025 results: EPS: ₹30.14 (down from ₹132 in FY 2024). Revenue: ₹3.75b (up 3.6% from FY 2024). Net income: ₹172.0m (down 77% from FY 2024). Profit margin: 4.6% (down from 21% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 13% per year whereas the company’s share price has increased by 15% per year.
New Risk • May 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (8.8% average weekly change). Profit margins are more than 30% lower than last year (11% net profit margin). Market cap is less than US$100m (₹5.14b market cap, or US$60.5m).
お知らせ • Mar 10Albert David Limited Announces Resignation of Shirish Gundopant Belapure as Independent DirectorAlbert David Limited announced that Mr. Shirish Gundopant Belapure has tendered his resignation as an Independent Director of the company, with effect from March 10, 2025.
Valuation Update With 7 Day Price Move • Feb 19Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to ₹879, the stock trades at a trailing P/E ratio of 12.4x. Average trailing P/E is 28x in the Pharmaceuticals industry in India. Total returns to shareholders of 69% over the past three years.
New Risk • Feb 13New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 12% Last year net profit margin: 19% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (12% net profit margin). Market cap is less than US$100m (₹6.29b market cap, or US$72.4m).
Reported Earnings • Feb 13Third quarter 2025 earnings released: ₹16.45 loss per share (vs ₹32.80 profit in 3Q 2024)Third quarter 2025 results: ₹16.45 loss per share (down from ₹32.80 profit in 3Q 2024). Revenue: ₹740.8m (down 16% from 3Q 2024). Net loss: ₹93.9m (down 150% from profit in 3Q 2024). Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth.
お知らせ • Feb 01Albert David Limited to Report Q3, 2025 Results on Feb 12, 2025Albert David Limited announced that they will report Q3, 2025 results at 12:15 PM, Indian Standard Time on Feb 12, 2025
Reported Earnings • Nov 17Second quarter 2025 earnings released: EPS: ₹31.67 (vs ₹35.57 in 2Q 2024)Second quarter 2025 results: EPS: ₹31.67 (down from ₹35.57 in 2Q 2024). Revenue: ₹1.19b (up 28% from 2Q 2024). Net income: ₹180.7m (down 11% from 2Q 2024). Profit margin: 15% (down from 22% in 2Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 31% per year and the company’s share price has also increased by 31% per year.
お知らせ • Nov 09Albert David Limited to Report Q2, 2025 Results on Nov 14, 2024Albert David Limited announced that they will report Q2, 2025 results on Nov 14, 2024
Buy Or Sell Opportunity • Aug 29Now 24% overvalued after recent price riseOver the last 90 days, the stock has risen 46% to ₹1,630. The fair value is estimated to be ₹1,314, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 8.3% over the last 3 years. Earnings per share has grown by 31%.
Valuation Update With 7 Day Price Move • Aug 28Investor sentiment improves as stock rises 24%After last week's 24% share price gain to ₹1,555, the stock trades at a trailing P/E ratio of 12.5x. Average trailing P/E is 39x in the Pharmaceuticals industry in India. Total returns to shareholders of 185% over the past three years.
お知らせ • Aug 09Albert David Limited Approves Dividend for the Financial Year Ended on March 31, 2024Albert David Limited at the Annual General Meeting held on August 9, 2024 approved declaration of Dividend of INR 11.50 per equity share of INR 10 each for the financial year ended on March 31, 2024.
Buy Or Sell Opportunity • Jul 29Now 20% overvalued after recent price riseOver the last 90 days, the stock has risen 11% to ₹1,326. The fair value is estimated to be ₹1,104, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years. Earnings per share has grown by 33%.
Upcoming Dividend • Jul 26Upcoming dividend of ₹11.50 per shareEligible shareholders must have bought the stock before 02 August 2024. Payment date: 08 September 2024. Payout ratio is a comfortable 8.7% and this is well supported by cash flows. Trailing yield: 0.9%. Lower than top quartile of Indian dividend payers (1.1%). Higher than average of industry peers (0.7%).
Reported Earnings • Jul 15Full year 2024 earnings released: EPS: ₹132 (vs ₹63.39 in FY 2023)Full year 2024 results: EPS: ₹132 (up from ₹63.39 in FY 2023). Revenue: ₹3.62b (up 6.1% from FY 2023). Net income: ₹754.2m (up 109% from FY 2023). Profit margin: 21% (up from 11% in FY 2023). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 33% per year whereas the company’s share price has increased by 34% per year.
Buy Or Sell Opportunity • Jul 01Now 23% overvalued after recent price riseOver the last 90 days, the stock has risen 22% to ₹1,362. The fair value is estimated to be ₹1,104, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years. Earnings per share has grown by 33%.
Buy Or Sell Opportunity • Jun 21Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 21% to ₹1,334. The fair value is estimated to be ₹1,104, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years. Earnings per share has grown by 33%.
Valuation Update With 7 Day Price Move • Jun 12Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₹1,270, the stock trades at a trailing P/E ratio of 9.6x. Average trailing P/E is 33x in the Pharmaceuticals industry in India. Total returns to shareholders of 155% over the past three years.
Declared Dividend • May 15Dividend of ₹11.50 announcedShareholders will receive a dividend of ₹11.50. Ex-date: 2nd August 2024 Payment date: 8th September 2024 Dividend yield will be 1.0%, which is higher than the industry average of 0.8%. Sustainability & Growth Dividend is well covered by both earnings (14% earnings payout ratio) and cash flows (15% cash payout ratio). The dividend has increased by an average of 7.2% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 34% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
お知らせ • May 15Albert David Limited, Annual General Meeting, Aug 09, 2024Albert David Limited, Annual General Meeting, Aug 09, 2024.
Reported Earnings • May 14Full year 2024 earnings released: EPS: ₹132 (vs ₹63.39 in FY 2023)Full year 2024 results: EPS: ₹132 (up from ₹63.39 in FY 2023). Revenue: ₹4.20b (up 23% from FY 2023). Net income: ₹754.2m (up 109% from FY 2023). Profit margin: 18% (up from 11% in FY 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has increased by 39% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • May 07Albert David Limited to Report Q4, 2024 Results on May 13, 2024Albert David Limited announced that they will report Q4, 2024 results on May 13, 2024
お知らせ • May 06Albert David Limited Announces Resignation of Abhishek Seth as Company Secretary & Compliance Officer, Effective May 31, 2024Albert David Limited informed that Mr. Abhishek Seth (ACS - 39671), Company Secretary & Compliance Officer, has resigned from the services of the Company effective May 31, 2024, in view of career opportunity outside the organization. In view of the resignation, Mr. Seth will also cease to be a Key Managerial Person under the provisions of Section 203 and other applicable provisions, if any, of the Companies Act, 2013 and Regulation 30(5) of the SEBI Listing Regulations for determining materiality of events /information for disclosure to the Stock Exchanges.
New Risk • Apr 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.5% average weekly change). Market cap is less than US$100m (₹6.90b market cap, or US$82.8m).
お知らせ • Mar 14Albert David Limited Announces Management ChangesAlbert David Limited at its board meeting held on 14 March 2024 announced that Based on the recommendation of the Nomination and Remuneration Committee of the Company, appointed Mr. Abhishek Seth (ACS-39671) as the Company Secretary & Compliance Officer, Nodal Officer (IEPF) and Chief Investor Relations Officer of the Company effective 14th March 2024 and Noted that Mr. Rajiv Singhi (DIN:00071285) and Mr. Hemal Kampani (DIN:00057715), Independent Directors of the Company, will be completing their second & final term as Independent Directors effective end of day 31st March 2024, and, thus, placed on record their appreciation for the retiring Directors. Reason for change of Mr. Abhishek Seth: In view of resignation of earlier Company Secretary & Compliance Officer-cum-Legal Head of the Company, and, based on recommendation of the Nomination and Remuneration Committee of the Company, the Board has appointed Mr. Abhishek Seth as the Company Secretary & Compliance Officer of the Company, who shall also function as the Nodal Officer (IEPF) and Chief Investor Relations Officer. Mr. Abhishek Seth is an Associate Member of the Institute of Company Secretaries of India (Membership No. 39671) and holds a Master's in Economics from University of Calcutta. He has around 9 years of post-qualification experience in the Corporate Secretarial and Compliance domain. He has been associated with Albert David Limited for nearly 8 years across Corporate Secretarial, Compliance and Finance functions. Prior to association with Albert David Limited, he was associated with Bengal Shelter Housing Development Limited as Company Secretary.
Reported Earnings • Feb 06Third quarter 2024 earnings released: EPS: ₹32.80 (vs ₹18.48 in 3Q 2023)Third quarter 2024 results: EPS: ₹32.80 (up from ₹18.48 in 3Q 2023). Revenue: ₹1.05b (up 41% from 3Q 2023). Net income: ₹187.2m (up 78% from 3Q 2023). Profit margin: 18% (up from 14% in 3Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has increased by 47% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Jan 26Albert David Limited to Report Q3, 2024 Results on Feb 05, 2024Albert David Limited announced that they will report Q3, 2024 results on Feb 05, 2024
Valuation Update With 7 Day Price Move • Jan 21Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹1,274, the stock trades at a trailing P/E ratio of 12.5x. Average trailing P/E is 35x in the Pharmaceuticals industry in India. Total returns to shareholders of 208% over the past three years.
お知らせ • Nov 23Albert David Limited Announces Resignation of A. B. Chakrabartty as Company Secretary and Compliance Officer Cum Legal Head of the CompanyAlbert David Limited announced that Mr. A. B. Chakrabartty (FCS 7184) has conveyed his decision to resign from the post of Company Secretary and Compliance Officer cum Legal Head of the Company, due to career opportunity outside the organization. He will continue to discharge his duties as the Company Secretary and Compliance Officer cum Legal Head of the Company, until the close of business hours on 19 January, 2024 to facilitate smooth transition. The Company has accepted his resignation. Mr. Chakrabartty will also cease to be a Key Managerial Personnel under the provisions of Section 203 and other applicable provisions, if any of the Companies Act, 2023 and Regulation 30(5) of SEBI LODR for determining the materiality of events or transactions for making the required disclosures to the Stock Exchanges effective close of business hours on January 19, 2024.
Reported Earnings • Nov 11Second quarter 2024 earnings released: EPS: ₹35.57 (vs ₹35.29 in 2Q 2023)Second quarter 2024 results: EPS: ₹35.57 (up from ₹35.29 in 2Q 2023). Revenue: ₹1.05b (up 14% from 2Q 2023). Net income: ₹203.0m (flat on 2Q 2023). Profit margin: 19% (down from 22% in 2Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has only increased by 27% per year, which means it is significantly lagging earnings growth.
お知らせ • Aug 11Albert David Limited Approves Dividend for the Financial Year Ended March 31, 2023Albert David Limited at its AGM held on August 10, 2023 approved dividend of INR 9.00 per equity share of INR 10.00 each for the financial year ended on 31st March, 2023.
Reported Earnings • Aug 11First quarter 2024 earnings released: EPS: ₹41.16 (vs ₹3.08 in 1Q 2023)First quarter 2024 results: EPS: ₹41.16 (up from ₹3.08 in 1Q 2023). Revenue: ₹1.10b (up 18% from 1Q 2023). Net income: ₹234.9m (up ₹217.4m from 1Q 2023). Profit margin: 21% (up from 1.9% in 1Q 2023). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has only increased by 18% per year, which means it is significantly lagging earnings growth.
お知らせ • Aug 03Albert David Limited to Report Q1, 2024 Results on Aug 10, 2023Albert David Limited announced that they will report Q1, 2024 results on Aug 10, 2023
Upcoming Dividend • Jul 27Upcoming dividend of ₹9.00 per share at 1.3% yieldEligible shareholders must have bought the stock before 03 August 2023. Payment date: 09 September 2023. Payout ratio is a comfortable 14% and the cash payout ratio is 98%. Trailing yield: 1.3%. Lower than top quartile of Indian dividend payers (1.5%). Higher than average of industry peers (0.9%).
Reported Earnings • May 21Full year 2023 earnings released: EPS: ₹63.39 (vs ₹61.78 in FY 2022)Full year 2023 results: EPS: ₹63.39 (up from ₹61.78 in FY 2022). Revenue: ₹3.57b (up 14% from FY 2022). Net income: ₹361.7m (up 2.6% from FY 2022). Profit margin: 10% (down from 11% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.
お知らせ • May 20+ 1 more updateAlbert David Limited, Annual General Meeting, Aug 10, 2023Albert David Limited, Annual General Meeting, Aug 10, 2023. Agenda: To consider dividend for the financial year ended March 31, 2023; and to consider directorate appointments.
お知らせ • May 13Albert David Limited to Report Q4, 2023 Results on May 19, 2023Albert David Limited announced that they will report Q4, 2023 results on May 19, 2023
Reported Earnings • Feb 15Third quarter 2023 earnings released: EPS: ₹18.48 (vs ₹13.96 in 3Q 2022)Third quarter 2023 results: EPS: ₹18.48 (up from ₹13.96 in 3Q 2022). Revenue: ₹745.7m (up 4.0% from 3Q 2022). Net income: ₹105.5m (up 32% from 3Q 2022). Profit margin: 14% (up from 11% in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth.
お知らせ • Feb 07Albert David Limited to Report Q3, 2023 Results on Feb 13, 2023Albert David Limited announced that they will report Q3, 2023 results on Feb 13, 2023
お知らせ • Feb 06+ 1 more updateAlbert David Limited Appoints Mr. A B Chakrabartty as the Company Secretary & Compliance Officer Cum Legal Head of the CompanyAlbert David Limited announced that at its board meeting held on February 04, 2023, the board approved the appointment of Mr. A B Chakrabartty as the Company Secretary & Compliance officer cum Legal Head of the company with effect from February 04, 2023.
Reported Earnings • Nov 16Second quarter 2023 earnings released: EPS: ₹35.29 (vs ₹22.20 in 2Q 2022)Second quarter 2023 results: EPS: ₹35.29 (up from ₹22.20 in 2Q 2022). Revenue: ₹1.06b (up 23% from 2Q 2022). Net income: ₹201.4m (up 59% from 2Q 2022). Profit margin: 19% (up from 15% in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has only increased by 14% per year, which means it is significantly lagging earnings growth.
お知らせ • Nov 05Albert David Limited to Report Q2, 2023 Results on Nov 12, 2022Albert David Limited announced that they will report Q2, 2023 results on Nov 12, 2022
お知らせ • Sep 14Albert David Limited Announces Reconstitution of Committees of the Board of DirectorsAlbert David Limited informed that the Board of Directors of the Company in their meeting held on 13 September 2022, has reconstituted the following Committees of the Board of Directors, with immediate effect. Stakeholder Relationship and Grievance Committee: Mr. Hemal Kampani, Chairman, Non-Executive Independent Director, Mr. Arun Kumar Kothari, Member, Executive Director, Mrs. Prabhawati Devi Kothari, Member, Non-Executive Director, Dr. Monjori Mitra, Member, Non-Executive Independent Director. Corporate Social Responsibility Committee: Mr. Arun Kumar Kothari, Chairman, Executive Director, Mrs. Prabhawati Devi Kothari, Member, Non-Executive Director, Mr. Arindam Sarkar, Member, Non-Executive Independent Director and Mr. S. G. Belapure, Member, Non-Executive Independent Director.
お知らせ • Sep 09Albert David Limited Announces Resignation of Tarminder Singh Parmar as Managing Director and CEO, Effective December 8, 2022Albert David Limited announced that Mr. Tarminder Singh Parmar, Managing Director and CEO has tendered his resignation from the office of Managing Director and CEO of the company with effect from the close of business hours on December 8, 2022.
お知らせ • Aug 17Albert David Limited Announces Management ChangesAlbert David Limited announced that Mr. Chirag A. Vora has tendered his resignation as Company Secretary and Compliance Officer of the Company, due to personal reasons. The Company has accepted his resignation and that Chirag will be relieved from the services of the Company close of business hours on 16 August, 2022. The Company has appointed Dr. Indrajit Dhar as the Compliance Officer of the Company with effect from 17 August, 2022. Brief Profile of Dr. I Dhar Dr. Indrajit Dhar is a qualified Chartered Accountant and Company Secretary being a Associate Member of the Institute of Company Secretaries of having more than 3 decades of post-qualification experience in the Accounts, Taxations, Finance and Secretarial. Presently, Dhar is designated as AVP Accounts and Taxations of the Company.
Upcoming Dividend • Jul 25Upcoming dividend of ₹9.00 per shareEligible shareholders must have bought the stock before 01 August 2022. Payment date: 08 September 2022. Payout ratio is a comfortable 15% and this is well supported by cash flows. Trailing yield: 1.5%. Lower than top quartile of Indian dividend payers (1.7%). Higher than average of industry peers (1.0%).
Reported Earnings • Jul 17Full year 2022 earnings releasedFull year 2022 results: Revenue: ₹3.14b (up 27% from FY 2021). Net income: ₹352.6m (up 59% from FY 2021). Profit margin: 11% (up from 8.9% in FY 2021).
お知らせ • Jul 06Albert David Limited, Annual General Meeting, Aug 09, 2022Albert David Limited, Annual General Meeting, Aug 09, 2022, at 11:00 Indian Standard Time.
Recent Insider Transactions • Jun 19Executive Chairman recently bought ₹1.1m worth of stockOn the 13th of June, Arun Kothari bought around 2k shares on-market at roughly ₹526 per share. In the last 3 months, they made an even bigger purchase worth ₹1.4m. Arun has been a buyer over the last 12 months, purchasing a net total of ₹7.3m worth in shares.
お知らせ • May 13+ 1 more updateAlbert David Limited Approves the Appointment of Anand Vardhan Kothari as an Additional Director (Non-Executive Non-Independent)Based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors of Albert David Limited has approved the appointment of Mr. Anand Vardhan Kothari (DIN: 02572346) as an Additional Director (Non-Executive Non-Independent) on the Board of the Company with immediate effect, i.e. from May 11, 2022, who shall hold office till the date of the forthcoming Annual General Meeting and shall continue to hold office thereafter, subject to approval of the shareholders at the forthcoming Annual General Meeting of the Company.
Reported Earnings • May 13Full year 2022 earnings released: EPS: ₹61.78 (vs ₹38.80 in FY 2021)Full year 2022 results: EPS: ₹61.78 (up from ₹38.80 in FY 2021). Revenue: ₹3.29b (up 33% from FY 2021). Net income: ₹352.6m (up 59% from FY 2021). Profit margin: 11% (up from 8.9% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.
Board Change • Apr 27Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 3 experienced directors. 4 highly experienced directors. Additional Non-Executive Independent Director Monjori Mitra was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Recent Insider Transactions • Apr 02Executive Chairman recently bought ₹536k worth of stockOn the 30th of March, Arun Kothari bought around 1k shares on-market at roughly ₹536 per share. In the last 3 months, they made an even bigger purchase worth ₹2.0m. Arun has been a buyer over the last 12 months, purchasing a net total of ₹4.6m worth in shares.
Board Change • Apr 01Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 3 experienced directors. 4 highly experienced directors. Additional Non-Executive Independent Director Monjori Mitra was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Recent Insider Transactions • Mar 16Executive Chairman recently bought ₹1.6m worth of stockOn the 9th of March, Arun Kothari bought around 3k shares on-market at roughly ₹521 per share. In the last 3 months, they made an even bigger purchase worth ₹2.0m. Arun has been a buyer over the last 12 months, purchasing a net total of ₹3.7m worth in shares.
Board Change • Mar 02Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 3 experienced directors. 4 highly experienced directors. Additional Non-Executive Independent Director Monjori Mitra was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Feb 17Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: ₹13.96 (up from ₹10.72 in 3Q 2021). Revenue: ₹777.3m (up 19% from 3Q 2021). Net income: ₹79.7m (up 30% from 3Q 2021). Profit margin: 10% (in line with 3Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Jan 03Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹676, the stock trades at a trailing P/E ratio of 10.6x. Average trailing P/E is 26x in the Pharmaceuticals industry in India. Total returns to shareholders of 71% over the past three years.
Reported Earnings • Nov 16Second quarter 2022 earnings released: EPS ₹22.20 (vs ₹17.16 in 2Q 2021)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2022 results: Revenue: ₹863.4m (up 20% from 2Q 2021). Net income: ₹126.7m (up 29% from 2Q 2021). Profit margin: 15% (in line with 2Q 2021). Over the last 3 years on average, earnings per share has increased by 11% per year whereas the company’s share price has increased by 13% per year.
Upcoming Dividend • Aug 30Upcoming dividend of ₹6.00 per shareEligible shareholders must have bought the stock before 06 September 2021. Payment date: 14 October 2021. Trailing yield: 1.0%. Lower than top quartile of Indian dividend payers (1.5%). Higher than average of industry peers (0.8%).
Reported Earnings • Aug 18First quarter 2022 earnings released: EPS ₹18.30 (vs ₹7.65 in 1Q 2021)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: ₹861.5m (up 37% from 1Q 2021). Net income: ₹104.5m (up 139% from 1Q 2021). Profit margin: 12% (up from 7.0% in 1Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 3% per year whereas the company’s share price has increased by 2% per year.
Valuation Update With 7 Day Price Move • Aug 12Investor sentiment improved over the past weekAfter last week's 19% share price gain to ₹634, the stock trades at a trailing P/E ratio of 16.3x. Average trailing P/E is 26x in the Pharmaceuticals industry in India. Total returns to shareholders of 18% over the past three years.
Reported Earnings • Jun 20Full year 2021 earnings released: EPS ₹38.80 (vs ₹33.59 in FY 2020)The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2021 results: Revenue: ₹2.47b (down 23% from FY 2020). Net income: ₹221.4m (up 16% from FY 2020). Profit margin: 8.9% (up from 6.0% in FY 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings.
Recent Insider Transactions • Apr 04Insider recently bought ₹189k worth of stockOn the 30th of March, Anand Kothari bought around 500 shares on-market at roughly ₹379 per share. In the last 3 months, there was an even bigger purchase from another insider worth ₹199k. Insiders have collectively bought ₹389k more in shares than they have sold in the last 12 months.
Recent Insider Transactions • Mar 31Executive Chairman recently bought ₹199k worth of stockOn the 22nd of March, Arun Kothari bought around 500 shares on-market at roughly ₹398 per share. This was the largest purchase by an insider in the last 3 months. This was Arun's only on-market trade for the last 12 months.
Is New 90 Day High Low • Feb 18New 90-day low: ₹399The company is down 4.0% from its price of ₹416 on 20 November 2020. The Indian market is up 21% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Pharmaceuticals industry, which is up 9.0% over the same period.
Reported Earnings • Feb 10Third quarter 2021 earnings released: EPS ₹10.72 (vs ₹9.20 in 3Q 2020)The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: ₹701.8m (down 12% from 3Q 2020). Net income: ₹61.2m (up 17% from 3Q 2020). Profit margin: 8.7% (up from 6.6% in 3Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 3% per year whereas the company’s share price has increased by 2% per year.
お知らせ • Feb 03Albert David Limited to Report Q3, 2021 Results on Feb 09, 2021Albert David Limited announced that they will report Q3, 2021 results on Feb 09, 2021
Is New 90 Day High Low • Nov 24New 90-day high: ₹459The company is up 1.0% from its price of ₹453 on 26 August 2020. The Indian market is up 10.0% over the last 90 days, indicating the company underperformed over that time. However, its price trend is similar to the Pharmaceuticals industry, which is also up 1.0% over the same period.
お知らせ • Nov 12+ 1 more updateAlbert David Limited Announces Executive ChangeAlbert David Limited announced Mr. Subhash Chandra Shah shall retire as Key Managerial Personnel with effect from close of business hours of 30 November, 2020. Mr. Ranadeep Bhattacharya will be appointed as Key Managerial Personnel of the Company with effect from 1st December, 2020.
Is New 90 Day High Low • Oct 27New 90-day low: ₹393The company is down 3.0% from its price of ₹405 on 29 July 2020. The Indian market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Pharmaceuticals industry, which is up 12% over the same period.
お知らせ • Aug 18Albert David Limited to Report Q1, 2021 Results on Aug 24, 2020Albert David Limited announced that they will report Q1, 2021 results on Aug 24, 2020
お知らせ • Jun 28Albert David Limited to Report Q4, 2020 Results on Jun 29, 2020Albert David Limited announced that they will report Q4, 2020 results on Jun 29, 2020
